David Baxley Spetzler, President at Caris Life Sciences, Inc. (CAI), bought 400 shares at $23.85 ($10K) on 2025-11-07, disclosed to the SEC on 2025-11-10.
Open-market purchase of $10k CAI by President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.